Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2022

Open Access 01-12-2022 | Hemolytic Anemia | Case report

A novel homozygous missense variant p.D339N in the PKLR gene correlates with pyruvate kinase deficiency in a Pakistani family: a case report

Authors: Atta Ur Rehman, Abdur Rashid, Zubair Hussain, Khadim Shah

Published in: Journal of Medical Case Reports | Issue 1/2022

Login to get access

Abstract

Background

Pyruvate kinase deficiency is an exceptionally rare autosomal recessive Mendelian disorder caused by bi-allelic pathogenic variants in the PKLR gene. It is mainly characterized by chronic nonspherocytic hemolytic anemia though other symptoms such as splenomegaly, hepatomegaly, pallor, fatigue, iron overload, shortness of breath, hyperbilirubinemia, and gallstones might also prevail.

Case presentation

We present here a novel genetic defect in the PKLR gene that correlates with pyruvate kinase deficiency phenotype in a consanguineous family from North-Western Pakistan. The family included three affected individuals who were all born to consanguineous parents. The proband, a 13-year-old female of Pashtun ethnicity, showed chronic nonautoimmune hemolytic anemia since birth, extremely low hemoglobin (7.6 g/dL) and pyruvate kinase (12.4 U/g Hb) levels, splenomegaly, and hepatomegaly. Bone marrow aspirate showed a markedly decreased myeloid to erythroid ratio and hypercellular marrow particles due to hyperplasia of the erythroid elements. Molecular characterization of the proband’s genomic DNA uncovered a likely pathogenic homozygous missense variant p.[D339N] in exon 7 of the PKLR gene. In-depth in silico analysis and familial cosegregation implies p.[D339N] as the likely cause of pyruvate kinase deficiency in this family. Further in vitro or in vivo studies are required to validate the impact of p.[D339N] on protein structure and/or stability, and to determine its role in the disease pathophysiology.

Conclusions

In summary, these findings suggest a novel genetic defect in the PKLR gene as a likely cause of pyruvate kinase deficiency, thus further expanding the mutational landscape of this rare Mendelian disorder.
Appendix
Available only for authorised users
Literature
1.
go back to reference Enegela OA, Anjum F. Pyruvate Kinase Deficiency, in StatPearls. 2021: Treasure Island (FL). Enegela OA, Anjum F. Pyruvate Kinase Deficiency, in StatPearls. 2021: Treasure Island (FL).
2.
go back to reference Secrest MH, et al. Prevalence of pyruvate kinase deficiency: a systematic literature review. Eur J Haematol. 2020;105:173–84.CrossRef Secrest MH, et al. Prevalence of pyruvate kinase deficiency: a systematic literature review. Eur J Haematol. 2020;105:173–84.CrossRef
3.
go back to reference Carey PJ, et al. Prevalence of pyruvate kinase deficiency in northern European population in the north of England. Northern Region Haematologists Group. Blood. 2000;96(12):4005–6.CrossRef Carey PJ, et al. Prevalence of pyruvate kinase deficiency in northern European population in the north of England. Northern Region Haematologists Group. Blood. 2000;96(12):4005–6.CrossRef
4.
go back to reference Bianchi P, Fermo E. Molecular heterogeneity of pyruvate kinase deficiency. Haematologica. 2020;105(9):2218–28.CrossRef Bianchi P, Fermo E. Molecular heterogeneity of pyruvate kinase deficiency. Haematologica. 2020;105(9):2218–28.CrossRef
5.
go back to reference Grace RF, Mark Layton D, Barcellini W. How we manage patients with pyruvate kinase deficiency. Br J Haematol. 2019;184(5):721–34.CrossRef Grace RF, Mark Layton D, Barcellini W. How we manage patients with pyruvate kinase deficiency. Br J Haematol. 2019;184(5):721–34.CrossRef
6.
go back to reference Fokkema I. et al. The LOVD3 platform: efficient genome-wide sharing of genetic variants. Eur J Hum Genet, 2021. Fokkema I. et al. The LOVD3 platform: efficient genome-wide sharing of genetic variants. Eur J Hum Genet, 2021.
7.
go back to reference Zanella A, Bianchi P. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations. Baillieres Best Pract Res Clin Haematol. 2000;13(1):57–81.CrossRef Zanella A, Bianchi P. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations. Baillieres Best Pract Res Clin Haematol. 2000;13(1):57–81.CrossRef
8.
go back to reference Zanella A, et al. Pyruvate kinase deficiency: the genotype-phenotype association. Blood Rev. 2007;21(4):217–31.CrossRef Zanella A, et al. Pyruvate kinase deficiency: the genotype-phenotype association. Blood Rev. 2007;21(4):217–31.CrossRef
9.
go back to reference van Bruggen R, et al. Modulation of malaria phenotypes by pyruvate kinase (PKLR) variants in a Thai population. PLoS ONE. 2015;10(12):e0144555.CrossRef van Bruggen R, et al. Modulation of malaria phenotypes by pyruvate kinase (PKLR) variants in a Thai population. PLoS ONE. 2015;10(12):e0144555.CrossRef
10.
go back to reference Berghout J, et al. Genetic diversity in human erythrocyte pyruvate kinase. Genes Immun. 2012;13(1):98–102.CrossRef Berghout J, et al. Genetic diversity in human erythrocyte pyruvate kinase. Genes Immun. 2012;13(1):98–102.CrossRef
11.
go back to reference Machado P, et al. Malaria: looking for selection signatures in the human PKLR gene region. Br J Haematol. 2010;149(5):775–84.CrossRef Machado P, et al. Malaria: looking for selection signatures in the human PKLR gene region. Br J Haematol. 2010;149(5):775–84.CrossRef
12.
go back to reference Boscoe AN, et al. Comorbidities and complications in adults with pyruvate kinase deficiency. Eur J Haematol. 2021;106(4):484–92.CrossRef Boscoe AN, et al. Comorbidities and complications in adults with pyruvate kinase deficiency. Eur J Haematol. 2021;106(4):484–92.CrossRef
13.
go back to reference Grace RF, et al. Erythrocyte pyruvate kinase deficiency: 2015 status report. Am J Hematol. 2015;90(9):825–30.CrossRef Grace RF, et al. Erythrocyte pyruvate kinase deficiency: 2015 status report. Am J Hematol. 2015;90(9):825–30.CrossRef
14.
go back to reference Kimmig LM, Palevsky HI. Review of the association between splenectomy and chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc. 2016;13(6):945–54.CrossRef Kimmig LM, Palevsky HI. Review of the association between splenectomy and chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc. 2016;13(6):945–54.CrossRef
15.
go back to reference van Beers EJ, et al. Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study. Haematologica. 2019;104(2):e51–3.CrossRef van Beers EJ, et al. Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study. Haematologica. 2019;104(2):e51–3.CrossRef
16.
go back to reference Untergasser A, et al. Primer3–new capabilities and interfaces. Nucleic Acids Res. 2012;40(15):e115.CrossRef Untergasser A, et al. Primer3–new capabilities and interfaces. Nucleic Acids Res. 2012;40(15):e115.CrossRef
17.
go back to reference Venselaar H, et al. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinf. 2010;11:548.CrossRef Venselaar H, et al. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinf. 2010;11:548.CrossRef
18.
go back to reference Vilar S, Cozza G, Moro S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem. 2008;8(18):1555–72.CrossRef Vilar S, Cozza G, Moro S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem. 2008;8(18):1555–72.CrossRef
19.
go back to reference Akin H, et al. Prevalence of erythrocyte pyruvate kinase deficiency and normal values of enzyme in a Turkish population. Hum Hered. 1997;47(1):42–6.CrossRef Akin H, et al. Prevalence of erythrocyte pyruvate kinase deficiency and normal values of enzyme in a Turkish population. Hum Hered. 1997;47(1):42–6.CrossRef
20.
go back to reference al-Naama MM, al-Naama LM, al-Sadoon TA. Glucose-6-phosphate dehydrogenase, hexokinase and pyruvate kinase activities in erythrocytes of neonates and adults in Basrah. Ann Trop Paediatr. 1994;14(3):195–200.CrossRef al-Naama MM, al-Naama LM, al-Sadoon TA. Glucose-6-phosphate dehydrogenase, hexokinase and pyruvate kinase activities in erythrocytes of neonates and adults in Basrah. Ann Trop Paediatr. 1994;14(3):195–200.CrossRef
21.
go back to reference Abu-Melha AM, et al. Erythrocyte pyruvate kinase deficiency in newborns of eastern Saudi Arabia. Acta Haematol. 1991;85(4):192–4.CrossRef Abu-Melha AM, et al. Erythrocyte pyruvate kinase deficiency in newborns of eastern Saudi Arabia. Acta Haematol. 1991;85(4):192–4.CrossRef
22.
go back to reference Yavarian M, et al. Prevalence of pyruvate kinase deficiency among the south Iranian population: quantitative assay and molecular analysis. Blood Cells Mol Dis. 2008;40(3):308–11.CrossRef Yavarian M, et al. Prevalence of pyruvate kinase deficiency among the south Iranian population: quantitative assay and molecular analysis. Blood Cells Mol Dis. 2008;40(3):308–11.CrossRef
23.
go back to reference Muir WA, Beutler E, Wasson C. Erythrocyte pyruvate kinase deficiency in the Ohio Amish: origin and characterization of the mutant enzyme. Am J Hum Genet. 1984;36(3):634–9.PubMedPubMedCentral Muir WA, Beutler E, Wasson C. Erythrocyte pyruvate kinase deficiency in the Ohio Amish: origin and characterization of the mutant enzyme. Am J Hum Genet. 1984;36(3):634–9.PubMedPubMedCentral
24.
go back to reference ur Rehman J, et al. Frequency of pyruvate kinase (PK) deficiency in neonates with haemolytic anaemia. PAFMJ. 2015;65(6):764–7. ur Rehman J, et al. Frequency of pyruvate kinase (PK) deficiency in neonates with haemolytic anaemia. PAFMJ. 2015;65(6):764–7.
Metadata
Title
A novel homozygous missense variant p.D339N in the PKLR gene correlates with pyruvate kinase deficiency in a Pakistani family: a case report
Authors
Atta Ur Rehman
Abdur Rashid
Zubair Hussain
Khadim Shah
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2022
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-022-03292-z

Other articles of this Issue 1/2022

Journal of Medical Case Reports 1/2022 Go to the issue